This inventor holds 20 USPTO granted patents and 16 published patent applications and 1 EPO patent, primarily in Drug Delivery Systems. Top assignees: Helsinn Healthcare Sa, Roche Palo Alto LLC, Durect Corporation. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
14 out of 70 
11 out of 322 
5 out of 93 
Years Active: 2011-2026
Areas of Expertise:
Title: The Innovative Journey of Andrew R Miksztal
Introduction
Andrew R Miksztal, a distinguished inventor based in Palo Alto, CA, has made significant contributions to pharmaceutical sciences through his impressive portfolio of 18 patents. His innovative work primarily focuses on drug compositions and delivery systems that have the potential to address various medical challenges, including organ failure and inflammatory diseases.
Latest Patents
Miksztal's latest patents showcase groundbreaking advancements in drug formulations. One notable patent involves compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) alongside cyclic oligosaccharides, such as cyclodextrin. These compositions are designed to prevent and treat a variety of diseases, including acute liver failure and high cholesterol. Another patent highlights his development of sustained release drug delivery systems that minimize impurities. This invention includes specific components like sucrose acetate isobutyrate and polyorthoesters, along with stringent limits on levels of certain compounds to ensure safety and efficacy of the drug formulations.
Career Highlights
Throughout his career, Andrew R Miksztal has worked at renowned companies in the healthcare sector, including Helsinn Healthcare SA and Roche Palo Alto LLC. His experience with these organizations has greatly influenced his innovative approach to drug development and composition.
Collaborations
Miksztal's success is partially attributed to his strategic collaborations with notable individuals in the industry, including Giorgio Calderari and Daniele Bonadeo. These partnerships have enhanced his research capabilities and broadened the impact of his inventions in the pharmaceutical domain.
Conclusion
Andrew R Miksztal exemplifies the spirit of innovation through his persistent efforts to develop novel pharmaceutical solutions. His extensive patent portfolio not only highlights his expertise but also reflects his commitment to advancing medical science for the betterment of society. The advancements he has contributed to will undoubtedly play a vital role in the future of healthcare and patient treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile